Thought Leaders
Opportunity Next.
Gear up to interact with the game changers. Hear, observe, learn and connect with the best of Industry Leaders and policy Influencers. BioAsia 2013 brings you the best of best under one roof on the 28th, 29th and 30th of January, 2013.
Be There.
He is also a member of the leadership team of the Prospective Strategic Initiative group at Sanofi-aventis. From 2005-2009, he served as the co-leader of the stem cell initiative and Distinguished Scientist at Sanofi-aventis.
Dr. Natesan received his Ph.D degree in Molecular Genetics from the University of Calgary and pursued his post-doctoral work at the Cold Spring Harbor Laboratories in New York. Dr. Natesan joined Ariad Pharmaceuticals in Cambridge, MA in 1994 as a Senior Research Scientist in its Gene Therapy Division. Later, he joined Aventis Pharmaceuticals as a Principal Scientist and led a group focused on cell based screens and stem cell biology. Dr. Natesan is one of the founding members of the AventisCambridgeGenomicsCenter and played a key role in the development of the center including as its Head of the Scientific Programs and member of the senior management for several years. He also served as the Head of Molecular Pharmacology at the center during this time.
Dr. Natesan is a member of the Industry Committee of International Society for Stem Cell Research (ISSCR). He is also member of the Outreach committee of the US India Chamber of Commerce. Dr. Natesan is responsible for setting up major academic alliances at Sanofi-aventis alliances including those with MIT and Harvard.
To Connect and Network with Freda C. Lewis-Hall Click Here
